A wide patent portfolio

Guard Therapeutics holds three granted international patent families. Additional patent applications are pending.

Taken together, these patents and patent applications cover the product as well as the medical use of ROSgard (and similar drug candidates) for the treatment of kidney damage and other diseases associated with oxidative stress.